What is Curative?
Curative is pioneering the future of health insurance with its innovative employer-based plan, backed by an AM Best rating of A-. The company's core mission is to revolutionize health insurance by dismantling financial obstacles to care and providing comprehensive guidance to members throughout their health journey. By offering a competitive monthly premium with no additional costs, Curative delivers substantial value, enhanced health outcomes, and increased peace of mind to employers and their employees.
How much funding has Curative raised?
Curative has raised a total of $150M across 1 funding round:
Series B
$150M
Series B (2025): $150M with participation from JAM Fund
Key Investors in Curative
JAM Fund
JAM Fund, associated with Alto Pharmacy, focuses on patient-centric healthcare solutions, aiming to build a more personalized and efficient pharmacy service for individuals seeking prescription medications and healthcare support.
What's next for Curative?
The substantial enterprise-level funding indicates Curative is poised for significant scaling and market expansion. This strategic investment will likely fuel further development of its unique employer-based health insurance model, potentially enabling broader outreach to businesses seeking cost-effective and outcome-driven healthcare solutions. Future growth may involve enhancing member support services, expanding network partnerships, and refining its technology platform to further streamline the healthcare experience.
See full Curative company page
